359 related articles for article (PubMed ID: 24725689)
21. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
23. Impact of incidental irradiation on clinically uninvolved nodal regions in patients with advanced non-small-cell lung cancer treated with involved-field radiation therapy: does incidental irradiation contribute to the low incidence of elective nodal failure?
Kimura T; Togami T; Nishiyama Y; Ohkawa M; Takashima H
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):337-43. PubMed ID: 19775827
[TBL] [Abstract][Full Text] [Related]
24. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT).
Yahalom J
Eur J Haematol Suppl; 2005 Jul; (66):90-7. PubMed ID: 16007875
[TBL] [Abstract][Full Text] [Related]
25. Recommendations for Radiotherapy Technique and Dose in Extra-nodal Lymphoma.
Hoskin PJ; Díez P; Gallop-Evans E; Syndikus I; Bates A; Bayne M;
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):62-8. PubMed ID: 26456507
[TBL] [Abstract][Full Text] [Related]
26. The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).
Mikhaeel NG; Milgrom SA; Terezakis S; Berthelsen AK; Hodgson D; Eich HT; Dieckmann K; Qi SN; Yahalom J; Specht L
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):501-512. PubMed ID: 30763664
[TBL] [Abstract][Full Text] [Related]
27. Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapy.
Hartmann Siantar CL; DeNardo GL; DeNardo SJ
J Nucl Med; 2003 Aug; 44(8):1322-9. PubMed ID: 12902424
[TBL] [Abstract][Full Text] [Related]
28. [Radiotherapy indications in non-Hodgkin lymphoma].
Quero L; Hennequin C; Brice P
Cancer Radiother; 2009 Oct; 13(6-7):471-8. PubMed ID: 19695926
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies.
Wong E; D'Souza DP; Chen JZ; Lock M; Rodrigues G; Coad T; Trenka K; Mulligan M; Bauman GS
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):830-41. PubMed ID: 15708263
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of helical tomotherapy for debulking irradiation before stem cell transplantation in malignant lymphoma.
Chargari C; Vernant JP; Tamburini J; Zefkili S; Fayolle M; Campana F; Fourquet A; Kirova YM
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1184-9. PubMed ID: 20646850
[TBL] [Abstract][Full Text] [Related]
31. Quality assurance of radiotherapy in a clinical trial for lymphoma: individual case review.
Shikama N; Oguchi M; Isobe K; Nakamura K; Tamaki Y; Hasegawa M; Kodaira T; Sasaki S; Kagami Y;
Anticancer Res; 2007; 27(4C):2621-5. PubMed ID: 17695424
[TBL] [Abstract][Full Text] [Related]
32. [IMRT combined to IGRT: increase of the irradiated volume. Consequences?].
Lisbona A; Averbeck D; Supiot S; Delpon G; Ali D; Vinas F; Diana C; Murariu C; Lagrange JL
Cancer Radiother; 2010 Oct; 14(6-7):563-70. PubMed ID: 20729117
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy studies and extra-nodal non-Hodgkin lymphomas, progress and challenges.
Specht L
Clin Oncol (R Coll Radiol); 2012 Jun; 24(5):313-8. PubMed ID: 22429802
[TBL] [Abstract][Full Text] [Related]
34. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
35. [Half-body irradiation in the combined therapy of disseminated lymphomas].
Kindzel'skiĭ LP; Pozmogov AI; Chernichenko VA; Lisetskiĭ VA; Nikishin BK; Sycheva TV; Tomilina NA
Med Radiol (Mosk); 1990 Jul; 35(7):9-13. PubMed ID: 2374489
[TBL] [Abstract][Full Text] [Related]
36. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
37. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.
Nielsen MH; Berg M; Pedersen AN; Andersen K; Glavicic V; Jakobsen EH; Jensen I; Josipovic M; Lorenzen EL; Nielsen HM; Stenbygaard L; Thomsen MS; Vallentin S; Zimmermann S; Offersen BV;
Acta Oncol; 2013 May; 52(4):703-10. PubMed ID: 23421926
[TBL] [Abstract][Full Text] [Related]
38. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
[TBL] [Abstract][Full Text] [Related]
39. [Hodgkin lymphoma and target definition guidelines].
Peignaux K; Gonzague-Casabianca L
Cancer Radiother; 2018 Sep; 22(5):401-403. PubMed ID: 30093312
[TBL] [Abstract][Full Text] [Related]
40. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
